Concepedia

Publication | Open Access

Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

78

Citations

25

References

2022

Year

Abstract

Capricor Therapeutics.

References

YearCitations

Page 1